skip-to-main

SPIKEVAX BIVALENT ORIGINAL/OMICRON (ELASOMERAN/IMELASOMERAN) COVID-19 VACCINE

SPIKEVAX BIVALENT ORIGINAL/OMICRON (elasomeran/imelasomeran) COVID-19 Vaccine has provisional approval for the indication below:

As a booster dose for active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in individuals 18 years of age and older.

Product Information

Product Information

Consumer Medicine Information

Consumer Medicine Information

Spikevax (previously COVID‑19 Vaccine Moderna)

SPIKEVAX (elasomeran) COVID-19 Vaccine has provisional approval for the indication below:

Active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in individuals 6 months of age and older.

Product Information

Product Information

Consumer Medicine Information

Consumer Medicine Information

Tools

Report Adverse Events

Report Adverse Events

Report any adverse events to Moderna via the Adverse Event Intake Portal or by calling 1800 344 018.

Contact Moderna

    © 2023 Moderna, Inc.

    AU-COV-2100002 08/2022